Mark T. Bradley
EVP, Chief Integration Officer · Keenova Therapeutics plc
Individual
- 2025
- Jul 31, 2025
- 1
Filings (90d)
0
Purchases
0
Sales
0
Summary
Latest filing:
Mark T. Bradley has 1 SEC Form 4 filing on record, dated 31 July 2025.
Recent transactions
1The latest SEC Form 4 transaction reported by Mark T. Bradley.
Most active insiders across the market
Mark T. Bradley has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- Ernesto Bertarelli - $219.00M in MAIR purchases and sales in the last 90 days
- TDR Capital II Investments LP - $202.40M in TH purchases and sales in the last 90 days
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 90 days
- Ronald N. Tutor - $197.71M in TPC purchases and sales in the last 90 days
- NIPPON LIFE INSURANCE CO - $194.45M in CRBG purchases and sales in the last 90 days
- Paul R. Vigano - $192.63M in AVAH purchases and sales in the last 90 days
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark T. Bradley?
Mark T. Bradley is a corporate insider, tracked as EVP, Chief Integration Officer. InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Mark T. Bradley last file a Form 4?
The only primary Form 4 on record is dated 31 July 2025.